Article covers a study published in the BMJ and co-authored by ISMP senior scientist that calculated a median pivotal clinical trial cost for new drugs in development, and offers a breakdown of possible factors leading to those costs.
For the full text, visit Endpoints News online.
More News
Regularly scheduled boosters are the most effective way to maintain normalcy in an endemic
New Recommendations Focus on Safe Use of Technology
This article from Kaiser Health News appeared on the CNN website on April 28, 2022.